In our laboratory, we have previously identified CRMP2 and Stk-17b as phosphorylation targets of PKCγ mediating the effects of increased PKC activity present in mouse models of SCA14 and in other forms of SCA [15–17, 68]. This evidence concerns the gene DPYSL2 and spinocerebellar ataxia type 14.